rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2000-3-16
|
pubmed:abstractText |
We evaluated the independent response rate of dexamethasone before docetaxel and estramustine administration as measured by changes in serum prostate specific antigen (PSA) in patients with androgen independent prostate cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0022-5347
|
pubmed:author |
pubmed-author:BagiellaEE,
pubmed-author:BensonMM,
pubmed-author:JudgeTT,
pubmed-author:KatzAA,
pubmed-author:NewhouseJ HJH,
pubmed-author:OlssonC ACA,
pubmed-author:OwenC ECE,
pubmed-author:PetrylakD PDP,
pubmed-author:PfaffCC,
pubmed-author:SawczukII,
pubmed-author:SheltonGG,
pubmed-author:WeitzmanA LAL,
pubmed-author:ZuechNN
|
pubmed:issnType |
Print
|
pubmed:volume |
163
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
834-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10687988-Adenocarcinoma,
pubmed-meshheading:10687988-Aged,
pubmed-meshheading:10687988-Antineoplastic Agents, Hormonal,
pubmed-meshheading:10687988-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:10687988-Dexamethasone,
pubmed-meshheading:10687988-Drug Administration Schedule,
pubmed-meshheading:10687988-Estramustine,
pubmed-meshheading:10687988-Humans,
pubmed-meshheading:10687988-Male,
pubmed-meshheading:10687988-Paclitaxel,
pubmed-meshheading:10687988-Prostate-Specific Antigen,
pubmed-meshheading:10687988-Prostatic Neoplasms,
pubmed-meshheading:10687988-Taxoids
|
pubmed:year |
2000
|
pubmed:articleTitle |
Dexamethasone does not significantly contribute to the response rate of docetaxel and estramustine in androgen independent prostate cancer.
|
pubmed:affiliation |
Department of Medicine, Columbia Presbyterian Medical Center, New York, New York 10032, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|